Regulatory Affairs Committee

The Regulatory Affairs Committee of ACRP holds responsibility to educate and work collaboratively with relevant regulatory agencies, legislatures, and other government entities to enhance the protection of human subjects that participate in clinical research and to advance the interests of the clinical research profession.. For further information on the Regulatory Affairs Committee’s goals, objectives, key responsibilities, and meeting schedule, please refer to the Committee Charge.

Current Regulatory Affairs Committee Members

Chair Linda Strause, PhD Executive Director and Head, Clinical Operations Vical Incorporated San Diego, CA	Yafit Stark, PhD Vice President, Chief Clinical Officer Teva Pharmaceutical Industries, Ltd. Netanya, Israel
Vice Chair Terri Hinkley, RN, BScN, MBA, CCRC Director, Clinical Operations Helix BioPharma Corp Ontario, Canada	Val Willetts, RN, BSN, CCRA President/CEO ASKA Research Vancouver, Canada
ABoT Liaison Norbert Clemens, MD, PhD  Head of Clinical Development and Managing Director CRS Mannheim GmbH Gruenstadt, Germany	Clara Heering, MSc, MSc Senior Director ClinOps Belgium Quintiles Vilvoorde, Belgium
Heike Schoen, MSc, MBA Managing Director CSG Clinische Studien Gesellschaft mbH Berlin, Germany	Peter Rheinstein, MD, JD, FAAFP President Severn Health Solutions Severna Park, MD
David Vulcano, LCSW, MBA, CIP, RAC AVP & Responsible Executive, Clinical Research Hospital Corporation of America Nashville, TN	Liz Wool, RN, BSN, CMT, CCRA President and CEO QD – Quality and Training Solutions, Inc. San Bruno, CA
Glenda Guest, BS, CCRA, RQAP-GCP Vice President Norwich Clinical Research Associates, Ltd. Norwich, NY